Followers | 10 |
Posts | 1146 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Monday, April 22, 2024 3:14:26 PM
Recent RANI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 08:10:35 PM
- Rani Therapeutics to Participate in September Investor Conferences • GlobeNewswire Inc. • 09/03/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:09:34 PM
- Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:04:18 PM
- Rani Therapeutics to Participate in August Investor Conferences • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 10:06:57 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/23/2024 10:05:12 AM
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:19:32 PM
- Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:53 PM
- Rani Therapeutics to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:09:53 PM
- Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:04:34 PM
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:10:21 PM
- Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:06:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:20 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM